Cathepsin cysteine protease inhibitors

1. A compound of the formula:

wherein

R 1 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 3-8 cycloalkyl or heterocyclyl, wherein said alkyl and alkenyl groups are optionally substituted with one to six substituents independently selected from the group consisting of hydroxy, C 3-6 cycloalkyl, halo and R 8 ; and wherein said cycloalkyl and heterocyclyl groups are optionally substituted with one or two substituents independently selected from the group consisting of C 1-6 alkyl, halo, OR 6 and keto;

R 2 is hydrogen, C 1-6 alkyl or C 2-6 alkenyl wherein said alkyl and alkenyl groups are optionally substituted with one to six substituents independently selected from the group consisting of hydroxy, C 3-6 cycloalkyl, halo and R 8 ;

or R 1 and R 2 can be taken together with the carbon atom to which they are attached to form a C 3-6 cycloalkyl or heterocyclyl ring wherein said cycloalkyl and heterocyclyl rings are optionally substituted with one to two substituents independently selected from the group consisting of R 6 , C 1-6 haloalkyl and halo;

each R 3 is independently selected from the group consisting of halo, and C 1-2 alkyl, wherein said alkyl group is optionally substituted with one to three halo; or

two R 3 groups on adjacent carbons can be taken together with the carbon atoms to which they are attached to form a C 3-4 cycloalkyl ring, wherein said ring is optionally substituted with one to three halo;

R 4a is aryl or heteroaryl, wherein said aryl and heteroaryl groups are optionally substituted with one to four substituents independently selected from the group consisting of halo, hydroxy, cyano, R 6 , OR 6 and R 8 ;

R 4b is hydrogen or C 1-6 alkyl which is optionally substituted with one to three substituents independently selected from the group consisting of halo, hydroxy, cyano and O(C 1-6 alkyl);

or R 4a and R 4b can be taken together with the atoms to which they are attached to form a 4 to 7 membered saturated or unsaturated ring wherein said ring is optionally substituted with one to two substituents independently selected from the group consisting of R 6 , C 1-6 haloalkyl and halo;

R 5 is hydrogen, C 1-6 alkyl, C 2-6 alkenyl, C 1-6 haloalkyl, aryl, heteroaryl, C 3-8 cycloalkyl, heterocycyl, C(O)NR 6 R 8 , C(O)R 8 , NR 6 C(O)OR 7 or SO m R 6 , wherein said aryl, heteroaryl, cycloalkyl and heterocycyl groups are optionally substituted with one to five substituents independently selected from the group consisting of C 1-6 alkyl, halo, oxo, cyano, C 1-6 haloalkyl, OR 6 , C(O)NR 6 R 7 , C(O)OR 6 , C(O)R 6 , ═NR 6 , ═NCN and SO m R 6 ;

R 6 is hydrogen or C 1-6 alkyl, which is optionally substituted with one to four substituents independently selected from the group consisting of halo, hydroxy, cyano, C 1-3 haloalkyl, and O(C 1-6 alkyl);

R 7 is hydrogen or C 1-6 alkyl, which is optionally substituted with one to three substituents independently selected from the group consisting of halo, hydroxy, cyano and O(C 1-6 alkyl);

R 8 is C 3-8 cycloalkyl, aryl, heteroaryl or heterocyclyl, wherein said cycloalkyl, aryl, heteroaryl and heterocyclyl groups are optionally substituted with one to four substituents independently selected from the group consisting of halo, cyano, oxo, R 6 , OR 6 , NR 6 R 7 , C 3-6 cycloalkyl, aryl, heteroaryl, heterocyclyl, SO m R 6 and SF 5 ;

m is an integer from zero to two;

p is an integer from zero to two;

or a pharmaceutically acceptable salt thereof.

2. The compound of claim 1 wherein R 1 is hydrogen or C 1-3 alkyl, wherein said alkyl group is optionally substituted with one to six halo; R 2 is hydrogen or C 1-3 alkyl, wherein said alkyl group is optionally substituted with one to six halo; or a pharmaceutically acceptable salt thereof.

3. The compound of claim 1 wherein or R 1 and R 2 can be taken together with the carbon atom to which they are attached to form a C 3-4 cycloalkyl ring; or a pharmaceutically acceptable salt thereof.

4. The compound of claim 1 wherein each R 3 is independently selected from the group consisting of hydrogen, halo or methyl, or two R 3 groups on adjacent carbons can be taken together with the carbon atoms to which they are attached to form a C 3-4 cycloalkyl ring, wherein said ring is optionally substituted with one to three halo; or a pharmaceutically acceptable salt thereof.

5. The compound of claim 1 wherein R 4a is aryl, wherein said aryl group is optionally substituted with one to four substituents independently selected from the group consisting of halo, hydroxy, cyano, R 6 , OR 6 and heteroaryl; or a pharmaceutically acceptable salt thereof.

6. The compound of claim 1 wherein R 4a is heteroaryl, wherein said heteroaryl group is optionally substituted with one to two substituents independently selected from the group consisting of halo, hydroxy, cyano and methyl; or a pharmaceutically acceptable salt thereof.

7. The compound of claim 1 wherein R 5 is heterocyclyl, C(O)R 8 or SO m R 6 , wherein said heterocycyl group is optionally substituted with one to five substituents independently selected from the group consisting of C 1-6 alkyl, halo, oxo, cyano, C 1-6 haloalkyl, OR 6 , C(O)NR 6 R 7 , C(O)OR 6 , C(O)R 6 , ═NR 6 , ═NCN and SO m R 6 ; or a pharmaceutically acceptable salt thereof.

8. The compound of claim 1 which is:

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(4-cyanopiperidin-1-yl)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-methoxyphenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1S,3R,4R,6R) or (1R,3R,4R,6S)—N-(1-cyanocyclopropyl)-4-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)bicyclo[4.1.0]heptane-3-carboxamide;

(1R,3R,4R,6S) or (1S,3R,4R,6R)—N-(1-cyanocyclopropyl)-4-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)bicyclo[4.1.0]heptane-3-carboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

isopropyl 3-(4-(3-((1R,2R)-2-((1-cyanocyclopropyl)carbamoyl)cyclohexyl)-1-(4-fluorophenyl)-1H-pyrazol-4-yl)phenyl)azetidine-1-carboxylate;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(6-methylpyridazin-3-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(5-chloropyridin-3-yl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-4,4-difluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-1H-pyrazol-3-yl)-5-fluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-5-(hydroxymethyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R,5S)—N—((S)-1-cyanoethyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluoropyridin-2-yl)-1H-pyrazol-3-yl)-5-fluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-5,5-difluoro-2-(3-(4-(morpholine-4-carbonyl)phenyl)pyrazolo[1,5-a]pyridin-2-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-5-fluoro-2-(1-(4-fluorophenyl)-4-(4-(1-(methyl imino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-5-fluoro-2-(1-(4-fluorophenyl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(4-(4-(1-(tert-butylimino)-1-oxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1-(cyanoimino)-1-oxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-4,4-difluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(3-(4-(1,1-dioxidothiomorpholino)phenyl)pyrazolo[1,5-a]pyridin-2-yl)cyclohexanecarboxamide;

(1R,2R)—N—((R or S)-1-cyanoethyl)-4,4-difluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S or R)-1-cyanoethyl)-4,4-difluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((R or S)-1-cyanoethyl)-4,4-difluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S or R)-1-cyanoethyl)-4,4-difluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-5-methyl-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-5-methyl-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(3-(4-(1,1-dioxidothiomorpholino)phenyl)pyrazolo[1,5-a]pyridin-2-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluoropyridin-2-yl)-1H-pyrazol-3-yl)-5-fluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-5-(hydroxymethyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-5-methyl-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluoropyridin-2-yl)-1H-pyrazol-3-yl)-4,4-difluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluoropyridin-2-yl)-1H-pyrazol-3-yl)-4,4-difluorocyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyanoethyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluoropyridin-2-yl)-1H-pyrazol-3-yl)-4,4-difluorocyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-4,4-difluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-4,4-difluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N—((S)-1-cyanoethyl)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-4,4-difluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-4,4-difluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluoropyridin-2-yl)-5-methyl-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyanoethyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluoropyridin-2-yl)-5-methyl-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluoropyridin-2-yl)-5-methyl-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(3-fluoropyridin-2-yl)-5-methyl-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide,

(1R,2R)—N—((S)-1-cyanoethyl)-4,4-difluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyanoethyl)-4,4-difluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyanoethyl)-2-(1-(3-fluoropyridin-2-yl)-5-methyl-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-2-(1-(3-fluoropyridin-2-yl)-5-methyl-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N—((S)-1-cyano-2-methylpropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluoropyridin-2-yl)-1H-pyrazol-3-yl)-5-fluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-5-methyl-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyanoethyl)-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-5-methyl-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-5-methyl-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-5-fluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N—((S)-1-cyanoethyl)-5-fluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N—((S)-1-cyano-2-methylpropyl)-5-fluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-5-fluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N—((S)-1-cyanoethyl)-5-fluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N—((S)-1-cyano-2-methylpropyl)-5-fluoro-2-(1-(3-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N—((S)-1-cyanoethyl)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyanoethyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-5-(hydroxymethyl)-1H-pyrazol-3-yl-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-5-(fluoromethyl)-1-(5-fluoropyridin-2-yl)-1H-pyrazol-3-yl)-5,5-di fluorocyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-5-(hydroxymethyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyanoethyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-5-(hydroxymethyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-5-(hydroxymethyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyanoethyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-5-methyl-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyanoethyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-5-(hydroxymethyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-5-(hydroxymethyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-5-(hydroxymethyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-5-(hydroxymethyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(5-(difluoromethyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyanoethyl)-2-(3-(4-(1,1-dioxidothiomorpholino)phenyl)pyrazolo[1,5-a]pyridin-2-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N—((S)-1-cyano-2-methylpropyl)-2-(3-(4-(1,1-dioxidothiomorpholino)phenyl)pyrazolo[1,5-a]pyridin-2-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N—((S or R)-1-cyano-3,3,3-trifluoropropyl)-2-(3-(4-(1,1-dioxidothiomorpholino)phenyl)pyrazolo[1,5-a]pyridin-2-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N—((R or S)-1-cyano-3,3,3-trifluoropropyl)-2-(3-(4-(1,1-dioxidothiomorpholino)phenyl)pyrazolo[1,5-a]pyridin-2-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R and 1S,2S)—N-(cyanomethyl)-5,5-difluoro-2-(4-(4-(methylsulfonyl)phenyl)-1-phenyl-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R and 1S,2S)—N-(cyanomethyl)-5,5-difluoro-2-(1-(4-fluorophenyl)-4-(4-(methyl sulfonyl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R and 1S,2S)—N-(cyanomethyl)-5,5-difluoro-2-(4-(4-(methylsulfonyl)phenyl)-1-(naphthalen-2-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R and 1S,2S)—N-(cyanomethyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R and 1S,2S)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N-(cyanomethyl)-2-(4-(4-(1,1-di oxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1S,2S)—N-(cyanomethyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1S,2S)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-5,5-difluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluorophenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-methoxyphenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-fluorophenyl)-4-(4-(morpholine-4-carbonyl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-fluorophenyl)-4-(4-(3-oxopiperazine-1-carbonyl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-fluorophenyl)-4-(4-(4-hydroxypiperidine-1-carbonyl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(2-cyanophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(2-methoxyphenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-fluorophenyl)-4-(4-(4-(methylsulfonyl)piperazine-1-carbonyl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-fluorophenyl)-4-(4-(3-(methylsulfonyl)azetidin-1-yl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(4-chlorophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1 cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-(2-hydroxypropan-2-yl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-(2-hydroxypropan-2-yl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(2-fluorophenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(3-chlorophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-cyanophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(3-cyanophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(2-chlorophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(4-cyano-2-methylphenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(2-chloro-4-cyanophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(4-chloro-2-cyanophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(2-cyano-4-fluorophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(2-cyano-4-methylphenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-4,4-di fluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(3-cyano-4-fluorophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-(difluoromethoxy)phenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-5-fluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-((S and R)-2,2,2-trifluoro-1-hydroxyethyl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(2,5-difluorophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(4-(4-(4-cyano-4-fluoropiperidin-1-yl)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R or 1S,2S)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-4,4-dimethylcyclohexanecarboxamide;

(1S,2S, or 1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-4,4-dimethylcyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(3,5-difluorophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-(trifluoromethoxy)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(2-(trifluoromethyl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-(trifluoromethyl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-(trifluoromethoxy)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(4-(1H-pyrazol-1-yl)phenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(2-(trifluoromethoxy)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R) or (1S,2S)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-5,5-dimethylcyclohexanecarboxamide;

(1S,2S) or (1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-5,5-dimethylcyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3,4,5-trifluorophenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-fluorophenyl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-fluorophenyl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(2,4-difluorophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(4-cyano-2-fluorophenyl)-4-(4-(1,1-di oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(2,6-difluorophenyl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(4-(4-(1-acetylazetidin-3-yl)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

3-(4-(3-((1R,2R)-2-((1-cyanocyclopropyl)carbamoyl)cyclohexyl)-1-(4-fluorophenyl)-1H-pyrazol-4-yl)phenyl)-N-methylazetidine-1-carboxamide;

3-(4-(3-((1R,2R)-2-((1-cyanocyclopropyl)carbamoyl)cyclohexyl)-1-(4-fluorophenyl)-1H-pyrazol-4-yl)phenyl)-N-(2,2,2-trifluoroethyl)azetidine-1-carboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(1H-indol-5-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1-(ethylimino)-1-oxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(4-fluorophenyl)-5-methyl-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-fluorophenyl)-4-(4-(1-(isopropylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(4-fluorophenyl)-4-(4-(1-oxido-1-((2,2,2-trifluoroethyl)imino)thiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(pyridin-2-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-(trifluoromethyl)pyridin-2-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(3-fluoropyridin-2-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(5-chloropyridin-2-yl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)-2-(1-(3-chloro-5-fluoropyridin-2-yl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(3,5-difluoropyridin-2-yl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-(trifluoromethyl)pyridin-2-yl)-1H-pyrazol-3-yl)-4,4-difluorocyclohexanecarboxamide;

(1R,2R)-2-(1-(5-chloropyridin-2-yl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)-4,4-difluorocyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-1H-pyrazol-3-yl)-4,4-difluorocyclohexanecarboxamide;

(1S,3R,4R,6R) or (1R,3R,4R,6S)—N-(1-cyanocyclopropyl)-4-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-1H-pyrazol-3-yl)bicyclo[4.1.0]heptane-3-carboxamide;

(1R,3R,4R,6S) or (1S,3R,4R,6R)—N-(1-cyanocyclopropyl)-4-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-1H-pyrazol-3-yl)bicyclo[4.1.0]heptane-3-carboxamide;

(1R,3R,4R,6S) or (1S,3R,4R,6R)-4-(1-(5-chloropyridin-2-yl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)bicyclo[4.1.0]heptane-3-carboxamide;

(1S,3R,4R,6R) or (1R,3R,4R,6S)-4-(1-(5-chloropyridin-2-yl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)-N-(1-cyanocyclopropyl)bicyclo[4.1.0]heptane-3-carboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-2-yl)-5-methyl-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-imino-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R,5S)—N-(1-cyanocyclopropyl)-5-fluoro-2-(1-(5-fluoropyridin-2-yl)-4-(4-(1-(methylimino)-1-oxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-(dioxidothiomorpholino)phenyl)-1-(pyrimidin-2-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(pyridazin-3-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(6-methoxypyridazin-3-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(pyridin-4-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(pyridin-3-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(5-fluoropyridin-3-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(6-(trifluoromethyl)pyridin-3-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(6-methylpyridin-3-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(6-methoxypyridin-3-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(1-(2,5-difluoropyridin-3-yl)-4-(4-(1,1-dioxidothiomorpholino)phenyl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1-(2-hydroxypyrimidin-5-yl)-1H-pyrazol-3-yl)cyclohexanecarboxamide;

(1R,2R)—N-(1-cyanocyclopropyl)-2-(4-(4-(1,1-dioxidothiomorpholino)phenyl)-1′-methyl-1′H-[1,4′-bipyrazol]-3-yl)cyclohexanecarboxamide;

or a pharmaceutically acceptable salt thereof.

9. A pharmaceutical composition comprising a compound according to claim 1 and a pharmaceutically acceptable carrier.

10. A method of treating osteoporosis, glucocorticoid induced osteoporosis, Paget's disease, abnormally increased bone turnover, periodontal disease, tooth loss, bone fractures, rheumatoid arthritis, osteoarthritis, periprosthetic osteolysis, osteogenesis imperfecta, atherosclerosis, obesity, glaucoma, chronic obstructive pulmonary disease, metastatic bone disease, hypercalcemia of malignancy or multiple myeloma in a mammal in need thereof with a compound of claim 1 .

11. A pharmaceutical composition comprising a compound of claim 1 and another agent selected from the group consisting of: an organic bisphosphonate, a selective estrogen receptor modulator, an estrogen receptor beta modulator, an androgen receptor modulator, an inhibitor of osteoclast proton ATPase, an inhibitor of HMG-CoA reductase, an integrin receptor antagonist, or an osteoblast anabolic agent, vitamin D, a synthetic Vitamin D analogue, a Nonsteroidal anti-inflammatory drug, a selective cyclooxygenase-2 inhibitor, an inhibitor of interleukin-1 beta, a LOX/COX inhibitor and the pharmaceutically acceptable salts and mixtures thereof.

12. A method of treating osteoporosis, glucocorticoid induced osteoporosis, Paget's disease, abnormally increased bone turnover, periodontal disease, tooth loss, bone fractures, rheumatoid arthritis, osteoarthritis, periprosthetic osteolysis, osteogenesis imperfecta, atherosclerosis, obesity, glaucoma, chronic obstructive pulmonary disease, metastatic bone disease, hypercalcemia of malignancy or multiple myeloma in a mammal in need thereof with a compound of claim 1 and another agent selected from the group consisting of: an organic bisphosphonate, a selective estrogen receptor modulator, an androgen receptor modulator, an inhibitor of osteoclast proton ATPase, an inhibitor of HMG-CoA reductase, an integrin receptor antagonist, an osteoblast anabolic agent, vitamin D, a synthetic Vitamin D analogue, a Nonsteroidal anti-inflammatory drug, a selective cyclooxygenase-2 inhibitor, an inhibitor of interleukin-1 beta, a LOX/COX inhibitor and the pharmaceutically acceptable salts and mixtures thereof.